2022
- Wiley Online Library - 01/13/22 - Incidence of SARS-CoV-2 infection among COVID-19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations, January–September 2021
- New England Journal of Medicine - 05/12/22 - Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers
2021
- Centers for Disease Control and Prevention - 03/02/21 - Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021
- Centers for Disease Control and Prevention - 03/02/21 - Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021
- Centers for Disease Control and Prevention - 03/18/21 - Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022
- New England Journal of Medicine - 06/22/21 - Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
- JAMA Network - 10/18/21 - Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers
- New England Journal of Medicine - 11/04/21 - Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
- ScienceDirect - 11/28/21 - COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers
- National Library of Medicine - 12/03/21 - Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER): Protocol for a Multisite Longitudinal Cohort Study
- Oxford Academic - 12/20/21 - Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection